Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 52, Issue 4
June 2006
Chemotherapy Cover Image for Volume 52, Issue 4
All Issues
ISSN 0009-3157
EISSN 1421-9794

Journal Name Change

Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.

Chemotherapy 2006, Vol. 52, No. 4

Review

Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Cardiovascular Risk
Subject Area: Further Areas , Oncology , Pharmacology
Giuseppe Barbaro; Giorgio Barbarini
Chemotherapy (2006) 52 (4): 161–165. https://doi.org/10.1159/000093034
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Microbiology

Chloroquine-Resistant Plasmodium falciparum Local Strain in Taiz Governorate, Republic of Yemen
Subject Area: Further Areas , Oncology , Pharmacology
Hussien O. Alkadi; Mohamed T. Al-Maktari; Majed A. Nooman
Chemotherapy (2006) 52 (4): 166–170. https://doi.org/10.1159/000093592
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Pharmacology

Trojan Horse Meets Magic Bullet to Spawn a Novel, Highly Effective Drug Delivery Model
Subject Area: Further Areas , Oncology , Pharmacology
Andras G. Lacko; Maya Nair; Sulabha Paranjape; Linda Mooberry; Walter J. McConathy
Chemotherapy (2006) 52 (4): 171–173. https://doi.org/10.1159/000093268
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Microbiology

Comparison of the Manual Mycobacteria Growth Indicator Tube and the Etest with the Method of Proportion for Susceptibility Testing of Mycobacterium tuberculosis
Subject Area: Further Areas , Oncology , Pharmacology
E. Fegou; E. Jelastopulu; S. Nicolaou; M. Sevdali; S. Anagnostou; S. Kanavaki; G. Dimitracopoulos; I. Spiliopoulou
Chemotherapy (2006) 52 (4): 174–177. https://doi.org/10.1159/000093035
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Clinical Study

Nephrotoxicity due to Combination Antibiotic Therapy with Vancomycin and Aminoglycosides in Septic Critically Ill Patients
Subject Area: Further Areas , Oncology , Pharmacology
Paolo Malacarne; Stefano Bergamasco; Carlo Donadio
Chemotherapy (2006) 52 (4): 178–184. https://doi.org/10.1159/000093269
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients
Subject Area: Further Areas , Oncology , Pharmacology
Pnina Chernobelski; Konstantin Lavrenkov; Doron Rimar; Klaris Riesenberg; Francisc Schlaeffer; Samuel Ariad; Wilmosh Mermershtain
Chemotherapy (2006) 52 (4): 185–189. https://doi.org/10.1159/000093036
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Microbiology

Susceptibility of Mycobacterium tuberculosis Strains to Gatifloxacin and Moxifloxacin by Different Methods
Subject Area: Further Areas , Oncology , Pharmacology
Sulochana Somasundaram; N. Chinnambedu Paramasivan
Chemotherapy (2006) 52 (4): 190–195. https://doi.org/10.1159/000093486
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Pharmacology

DNA-Spermine and DNA-Lipid Aggregate Formation Visualized by Fluorescence Correlation Spectroscopy
Subject Area: Further Areas , Oncology , Pharmacology
Teresa Kral; Marek Langner; Martin Hof
Chemotherapy (2006) 52 (4): 196–199. https://doi.org/10.1159/000093270
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Clinical Study

Review of Pharmacokinetic, Pharmacodynamic and Clinical Studies with a Modern Combination of Amoxicillin/Sulbactam
Subject Area: Further Areas , Oncology , Pharmacology
J. Soutric; C. Bantar; N. Caruso; R. Heguilén; J.M. Casellas Jr.; J.M. Casellas; A. Farinati; A. Jasovich; H. Arenoso; M. Rodriguez
Chemotherapy (2006) 52 (4): 200–204. https://doi.org/10.1159/000093593
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Pharmacology

Potential New Antimalarial Chemotherapeutics Based on Sphingolipid Metabolism
Subject Area: Further Areas , Oncology , Pharmacology
Irene Pankova-Kholmyansky; Eliezer Flescher
Chemotherapy (2006) 52 (4): 205–209. https://doi.org/10.1159/000093037
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Decreased Phosphoactive ERKs and JNKs in Malachite-Green-Transformed Syrian Hamster Embryo Fibroblasts Are Associated with Increased Phosphoactive p38 Kinase: Possible Therapeutic Importance
Subject Area: Further Areas , Oncology , Pharmacology
Bipasha Bose; Rekha R. Gour; Leena Motiwale; K.V.K. Rao
Chemotherapy (2006) 52 (4): 210–214. https://doi.org/10.1159/000093038
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Aerobic exercise alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis
Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
Safety and Efficacy of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Pegfilgrastim in Japanese Patients with Advanced or Metastatic Urothelial Carcinoma
  • Online ISSN 1421-9794
  • Print ISSN 0009-3157
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal